000 | 01951 a2200541 4500 | ||
---|---|---|---|
005 | 20250516220520.0 | ||
264 | 0 | _c20141126 | |
008 | 201411s 0 0 eng d | ||
022 | _a1365-2249 | ||
024 | 7 |
_a10.1111/cei.12400 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRitter, M | |
245 | 0 | 0 |
_aFunctional relevance of NLRP3 inflammasome-mediated interleukin (IL)-1β during acute allergic airway inflammation. _h[electronic resource] |
260 |
_bClinical and experimental immunology _cNov 2014 |
||
300 |
_a212-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xdeficiency |
650 | 0 | 4 | _aCARD Signaling Adaptor Proteins |
650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEosinophilia _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGoblet Cells _xpathology |
650 | 0 | 4 | _aHyperplasia |
650 | 0 | 4 |
_aInflammasomes _xmetabolism |
650 | 0 | 4 |
_aInterleukin 1 Receptor Antagonist Protein _xadministration & dosage |
650 | 0 | 4 |
_aInterleukin-1beta _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aNLR Family, Pyrin Domain-Containing 3 Protein |
650 | 0 | 4 |
_aOvalbumin _xadverse effects |
650 | 0 | 4 |
_aPneumonia _xgenetics |
650 | 0 | 4 |
_aReceptors, Interleukin-1 Type I _xdeficiency |
650 | 0 | 4 |
_aRespiratory Hypersensitivity _xchemically induced |
650 | 0 | 4 |
_aT-Lymphocytes, Helper-Inducer _ximmunology |
700 | 1 | _aStraubinger, K | |
700 | 1 | _aSchmidt, S | |
700 | 1 | _aBusch, D H | |
700 | 1 | _aHagner, S | |
700 | 1 | _aGarn, H | |
700 | 1 | _aPrazeres da Costa, C | |
700 | 1 | _aLayland, L E | |
773 | 0 |
_tClinical and experimental immunology _gvol. 178 _gno. 2 _gp. 212-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/cei.12400 _zAvailable from publisher's website |
999 |
_c23932662 _d23932662 |